Cancer is a major societal challenge. The combination of novel imaging and computational techniques with advanced therapeutic strategies is key to early diagnosis, exact tumour characterisation and successful treatment. The goal of GRK2274 is to promote young scientists from natural sciences and medicine in this rapidly growing field of medical physics. GRK2274 covers basic, translational and clinical research, building upon a long tradition of excellence in biomedical research in Munich from the two universities (LMU, TUM) and the research centre HMGU. This multidisciplinary and interdisciplinary research programme will touch upon innovative areas of computing (research area A), imaging (research area B) and therapy (research area C), addressed in synergistic PhD and MD projects with the common goal to advance image-guided cancer therapy. The original qualification concept features a broad spectrum of compulsory and eligible training activities in order to ensure not only academic excellence and scientific independence, but also the development of fundamental personal effectiveness. GRK2274 provides an ideal platform to promote innovations in oncology with a potentially high societal impact, thus forming the next generation of scientists with excellent career prospects in academia, clinical practice and industry.
Additional support is offered by the GraduateCenter.